유소열 (서울대학교 약학대학)님 | 한빛사연구자 > 한빛사

서울대학교 약학대학

최종업데이트 2026.04.24.

Inhalable nanohybrid of delpazolid enhances antimicrobial host defense against mycobacterial pulmonary infection
- J. Control. Release, Available online 22 April 2026, 114950 | https://doi.org/10.1016/j.jconrel.2026.114950
- 2026-04
- 의약학
- 한빛사논문
Dual-Light-Primed GSH-Scavenging Lipid Hybrid Nanoplatform for Cascade-Activated Photodynamic Therapy
- Small, Feb 09 2026, | https://doi.org/10.1002/smll.202512546
- 2026-02
- 의약학
- 한빛사논문
Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc- in liver cancer: A non-ferroptotic approach
- J. Control. Release, Sep 16 2024, S0168-3659(24)00639-4 | https://doi.org/10.1016/j.jconrel.2024.09.029
- 2024-09
- 의약학
- 한빛사논문
Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate-decorated albumin nanoclusters in osteosarcoma treatment
- Bioeng. Transl. Med., First published: 26 December 2022 | https://doi.org/10.1002/btm2.10472
- 2022-12
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문